Literature DB >> 21830928

Bayesian hierarchical modeling for detecting safety signals in clinical trials.

H Amy Xia1, Haijun Ma, Bradley P Carlin.   

Abstract

Detection of safety signals from clinical trial adverse event data is critical in drug development, but carries a challenging statistical multiplicity problem. Bayesian hierarchical mixture modeling is appealing for its ability to borrow strength across subgroups in the data, as well as moderate extreme findings most likely due merely to chance. We implement such a model for subject incidence (Berry and Berry, 2004 ) using a binomial likelihood, and extend it to subject-year adjusted incidence rate estimation under a Poisson likelihood. We use simulation to choose a signal detection threshold, and illustrate some effective graphics for displaying the flagged signals.

Mesh:

Year:  2011        PMID: 21830928     DOI: 10.1080/10543406.2010.520181

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  7 in total

1.  Efficient methods for signal detection from correlated adverse events in clinical trials.

Authors:  Guoqing Diao; Guanghan F Liu; Donglin Zeng; William Wang; Xianming Tan; Joseph F Heyse; Joseph G Ibrahim
Journal:  Biometrics       Date:  2019-03-29       Impact factor: 2.571

2.  A hierarchical testing approach for detecting safety signals in clinical trials.

Authors:  Xianming Tan; Bingshu E Chen; Jianping Sun; Tejendra Patel; Joseph G Ibrahim
Journal:  Stat Med       Date:  2020-02-12       Impact factor: 2.373

3.  Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods.

Authors:  Janus Christian Jakobsen; Jørn Wetterslev; Per Winkel; Theis Lange; Christian Gluud
Journal:  BMC Med Res Methodol       Date:  2014-11-21       Impact factor: 4.615

Review 4.  Statistical methods for the analysis of adverse event data in randomised controlled trials: a scoping review and taxonomy.

Authors:  Rachel Phillips; Odile Sauzet; Victoria Cornelius
Journal:  BMC Med Res Methodol       Date:  2020-11-30       Impact factor: 4.615

5.  BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA®-Coded Adverse Events in Randomized Controlled Trials.

Authors:  Alma Revers; Michel H Hof; Aeilko H Zwinderman
Journal:  Drug Saf       Date:  2022-07-15       Impact factor: 5.228

6.  The FDA's Final Rule on Expedited Safety Reporting: Statistical Considerations.

Authors:  Janet Wittes; Brenda Crowe; Christy Chuang-Stein; Achim Guettner; David Hall; Qi Jiang; Daniel Odenheimer; H Amy Xia; Judith Kramer
Journal:  Stat Biopharm Res       Date:  2015-10-09       Impact factor: 1.452

7.  Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials.

Authors:  Junhao Liu; Jo Wick; Renee' H Martin; Caitlyn Meinzer; Dooti Roy; Byron Gajewski
Journal:  BMC Med Res Methodol       Date:  2020-08-17       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.